The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The versatility and universality of calcium signalling
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036035 · Cited by 5,701
Cellular and Molecular Mechanisms of Pain
Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009) · Cell · doi:10.1016/j.cell.2009.09.028 · Cited by 4,344
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Central sensitization: a generator of pain hypersensitivity by central neural plasticity
Latremoliere, A., & Woolf, C. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.012 · Cited by 3,913
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Microtubule-binding agents: a dynamic field of cancer therapeutics
Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,718
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Chemotherapy-induced peripheral neuropathy
Quasthoff, S., & Hartung, H. P. (2002) · Journal of Neurology · doi:10.1007/pl00007853 · Cited by 966
Raghavendra, V., Tanga, F., & DeLeo, J. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052407 · Cited by 797
Zhuang, Z.-Y., Gerner, P., Woolf, C. J., & Ji, R.-R. (2005) · Pain · doi:10.1016/j.pain.2004.12.022 · Cited by 774
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Replication and Transcription of Vertebrate Mitochondrial DNA
Clayton, D. A. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.002321 · Cited by 635
The mitochondrial permeability transition from in vitro artifact to disease target
Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blalchy‐Dyson, E., Di Lisa, F., & Forte, M. A. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05213.x · Cited by 627
Chemotherapy‐induced neuropathy
Windebank, A. J., & Grisold, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00156.x · Cited by 613
TRPA1 acts as a cold sensor in vitro and in vivo
Karashima, Y., Talavera, K., Everaerts, W., Janssens, A., Kwan, K. Y., Vennekens, R., Nilius, B., & Voets, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808487106 · Cited by 585
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Flatters, S. J. L., & Bennett, G. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.037 · Cited by 535
Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond, É., Faivre, S. J., WOYNAROWSKI, J. M., & Chaney, S. G. (1998) · PubMed · Cited by 520
Axonal mitochondrial transport and potential are correlated
Miller, K. E., & Sheetz, M. P. (2004) · Journal of Cell Science · doi:10.1242/jcs.01130 · Cited by 511
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan, S., Smith, M. L., Rivet, D. J., Duba, D. E., Zhan, Q., Kohn, K. W., Fornace, A. J., & O'Connor, P. M. (1995) · PubMed · Cited by 490
Bad news from the brain: descending 5-HT pathways that control spinal pain processing
Suzuki, R., Rygh, L. J., & Dickenson, A. H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.002 · Cited by 482
Montero, M., Alonso, M. T., Carnicero, E., Cuchillo-Ibáñez, I., Albillos, A., García, A. G., García-Sancho, J., & Alvarez, J. (2000) · Nature Cell Biology · doi:10.1038/35000001 · Cited by 471
TRPA1 is a major oxidant sensor in murine airway sensory neurons
Bessac, B. F., Sivula, M., von Hehn, C. A., Escalera, J., Cohn, L., & Jordt, S.-E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34192 · Cited by 449
Ciarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenstädt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A. H., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090610 · Cited by 444
Argyriou, A. A., Iconomou, G., & Kalofonos, H. P. (2008) · Blood · doi:10.1182/blood-2008-04-149385 · Cited by 432
Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions
Mayer, D. J., Mao, J., Holt, J., & Price, D. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7731 · Cited by 423
Furuta, T., Ueda, T., Aune, G. J., Sarasin, A. R., Kraemer, K. H., & Pommier, Y. G. (2002) · PubMed · Cited by 422
Molecular mechanisms involved in cisplatin cytotoxicity
Jordan, P., & Carmo-Fonseca*, M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000762 · Cited by 398
Mitochondrial Trafficking to Synapses in Cultured Primary Cortical Neurons
Chang, D. T. W., Honick, A. S., & Reynolds, I. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1012-06.2006 · Cited by 395
Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
Thompson, S. W., Davis, L. E., Kornfeld, M., Hilgers, R. D., & Standefer, J. C. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7<1269::aid-cncr2820540707>3.0.co;2-9 · Cited by 394
Dougherty, P. M., Cata, J. P., Cordella, J. V., Burton, A., & Weng, H.-R. (2004) · Pain · doi:10.1016/j.pain.2004.01.021 · Cited by 369
Descoeur, J., Pereira, V., Pizzoccaro, A., Francois, A., Ling, B., Maffre, V., Couette, B., Busserolles, J., Courteix, C., Noel, J., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100134 · Cited by 368
Immune regulation of central nervous system functions: from sickness responses to pathological pain
WATKINS, L. R., & MAIER, S. F. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01443.x · Cited by 366
The Role of Sodium Channels in Chronic Inflammatory and Neuropathic Pain
Amir, R., Argoff, C. E., Bennett, G. J., Cummins, T. R., Durieux, M. E., Gerner, P., Gold, M. S., Porreca, F., & Strichartz, G. R. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2006.01.444 · Cited by 362
Gregg, R. W., Molepo, J. M., Monpetit, V. J., Mikael, N. Z., Redmond, D., Gadia, M., & Stewart, D. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.795 · Cited by 358
Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy
Jaggi, A. S., & Singh, N. (2012) · Toxicology · doi:10.1016/j.tox.2011.10.019 · Cited by 358
Grolleau, F., Gamelin, L., Boisdron-Celle, M., Lapied, B., Pelhate, M., & Gamelin, E. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.5.2293 · Cited by 344
Substoichiometric Binding of Taxol Suppresses Microtubule Dynamics
Derry, W. B., Wilson, L., & Jordan, M. A. (1995) · Biochemistry · doi:10.1021/bi00007a014 · Cited by 335
Ta, L. E., Espeset, L., Podratz, J., & Windebank, A. J. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.04.010 · Cited by 325
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation
Nassini, R., Gees, M., Harrison, S., De Siena, G., Materazzi, S., Moretto, N., Failli, P., Preti, D., Marchetti, N., Cavazzini, A., et al. (2011) · Pain · doi:10.1016/j.pain.2011.02.051 · Cited by 324
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
Podratz, J. L., Knight, A. M., Ta, L. E., Staff, N. P., Gass, J. M., Genelin, K., Schlattau, A., Lathroum, L., & Windebank, A. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.017 · Cited by 320
Ledeboer, A., Jekich, B. M., Sloane, E. M., Mahoney, J. H., Langer, S. J., Milligan, E. D., Martin, D., Maier, S. F., Johnson, K. W., Leinwand, L. A., et al. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.10.012 · Cited by 308
SIAU, C., XIAO, W., & BENNETT, G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.007 · Cited by 300
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub4 · Cited by 298
VINCRISTINE NEUROPATHY: CLINICAL AND ELECTROPHYSIOLOGICAL OBSERVATIONS
CASEY, E. B., JELLIFE, A. M., LE QUESNE, P. M., & MILLETT, Y. L. (1973) · Brain · doi:10.1093/brain/96.1.69 · Cited by 293
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
Adelsberger, H., Quasthoff, S., Grosskreutz, J., Lepier, A., Eckel, F., & Lersch, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00667-1 · Cited by 290
Effects of temperature on neuromuscular electrophysiology
Rutkove, S. B. (2001) · Muscle & Nerve · doi:10.1002/mus.1084 · Cited by 288
Peters, C. M., Jimenez-Andrade, J. M., Jonas, B. M., Sevcik, M. A., Koewler, N. J., Ghilardi, J. R., Wong, G. Y., & Mantyh, P. W. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.07.022 · Cited by 288
TRPA1 Contributes to Cold Hypersensitivity
del Camino, D., Murphy, S., Heiry, M., Barrett, L. B., Earley, T. J., Cook, C. A., Petrus, M. J., Zhao, M., D'Amours, M., Deering, N., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2580-10.2010 · Cited by 287
Carreá, M., Andreá, N., Carles, G., Borghi, H., Brichese, L., Briand, C., & Braguer, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203834200 · Cited by 273
Zheng, H., Xiao, W. H., & Bennett, G. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.016 · Cited by 272
Oxaliplatin-Associated Neuropathy: A Review
Cersosimo, R. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e319 · Cited by 268
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
Cavaletti, G., Gilardini, A., Canta, A., Rigamonti, L., Rodriguez-Menendez, V., Ceresa, C., Marmiroli, P., Bossi, M., Oggioni, N., D'Incalci, M., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.010 · Cited by 265
Self-citationIodo-Resiniferatoxin, a New Potent Vanilloid Receptor Antagonist
Wahl, P., Foged, C., Tullin, S., & Thomsen, C. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12350-4 · Cited by 260
The Area Postrema: A Brain Monitor and Integrator of Systemic Autonomic State
Price, C. J., Hoyda, T. D., & Ferguson, A. V. (2008) · The Neuroscientist · doi:10.1177/1073858407311100 · Cited by 257
Pan, H., Mukhopadhyay, P., Rajesh, M., Patel, V., Mukhopadhyay, B., Gao, B., Haskó, G., & Pacher, P. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147181 · Cited by 251
Copper-related diseases: From chemistry to molecular pathology
Crisponi, G., Nurchi, V. M., Fanni, D., Gerosa, C., Nemolato, S., & Faa, G. (2010) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.12.018 · Cited by 249
Mitochondrial DNA repair pathways
Croteau, D. L., Stierum, R. H., & Bohr, V. A. (1999) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00025-7 · Cited by 240
Peripheral nerve damage associated with administration of taxanes in patients with cancer
Argyriou, A. A., Koltzenburg, M., Polychronopoulos, P., Papapetropoulos, S., & Kalofonos, H. P. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.008 · Cited by 240
Land, S. R., Kopec, J. A., Cecchini, R. S., Ganz, P. A., Wieand, H. S., Colangelo, L. H., Murphy, K., Kuebler, J. P., Seay, T. E., Needles, B. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6652 · Cited by 239
Zhang, Y., Fujita, N., & Tsuruo, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202426 · Cited by 237
Strumberg, D., Brügge, S., Korn, M. W., Koeppen, S., Ranft, J., Scheiber, G., Reiners, C., Möckel, C., Seeber, S., & Scheulen, M. E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf058 · Cited by 232
McDonald, E. S., Randon, K. R., Knight, A., & Windebank, A. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.013 · Cited by 227
Alessandri-Haber, N., Dina, O. A., Joseph, E. K., Reichling, D. B., & Levine, J. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4497-07.2008 · Cited by 226
DNA repair in terminally differentiated cells
Nouspikel, T. (2002) · DNA Repair · doi:10.1016/s1568-7864(01)00005-2 · Cited by 225
Materazzi, S., Fusi, C., Benemei, S., Pedretti, P., Patacchini, R., Nilius, B., Prenen, J., Creminon, C., Geppetti, P., & Nassini, R. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1071-x · Cited by 224
Rodi, D. J., Janes, R. W., Sanganee, H. J., Holton, R. A., Wallace, B. A., & Makowski, L. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2303 · Cited by 223
Broyl, A., Corthals, S. L., Jongen, J. L., van der Holt, B., Kuiper, R., de Knegt, Y., van Duin, M., el Jarari, L., Bertsch, U., Lokhorst, H. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70206-0 · Cited by 219
Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721
Mollman, J. E., Glover, D. J., Hogan, W. M., & FURMAN, R. E. (1988) · Cancer · doi:10.1002/1097-0142(19880601)61:11<2192::aid-cncr2820611110>3.0.co;2-a · Cited by 219
Neuronal Apoptosis in Neurodegeneration
Okouchi, M., Ekshyyan, O., Maracine, M., & Aw, T. Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1511 · Cited by 218
Oxaliplatin‐induced neurotoxicity and the development of neuropathy
Krishnan, A. V., Goldstein, D., Friedlander, M., & Kiernan, M. C. (2005) · Muscle & Nerve · doi:10.1002/mus.20340 · Cited by 216
Lobert, S., Vulevic, B., & Correia, J. J. (1996) · Biochemistry · doi:10.1021/bi953037i · Cited by 212
Joseph, E. K., Chen, X., Bogen, O., & Levine, J. D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2008.01.335 · Cited by 210
Park, S., Krishnan, A., Lin, C., Goldstein, D., Friedlander, M., & Kiernan, M. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786848569 · Cited by 208
Kidd, J. F., Pilkington, M. F., Schell, M. J., Fogarty, K. E., Skepper, J. N., Taylor, C. W., & Thorn, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106802200 · Cited by 205
Caspase signalling in neuropathic and inflammatory pain in the rat
Joseph, E. K., & Levine, J. D. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03750.x · Cited by 205
Melli, G., Taiana, M., Camozzi, F., Triolo, D., Podini, P., Quattrini, A., Taroni, F., & Lauria, G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.013 · Cited by 202
Landowski, T. H., Megli, C. J., Nullmeyer, K. D., Lynch, R. M., & Dorr, R. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3684 · Cited by 202
André, N., Braguer, D., Brasseur, G., Gonçalvès, A., Lemesle-Meunier, D., Guise, S., Jordan, M. A., & Briand, C. M. (2000) · PubMed · Cited by 195
Mannelli, L. D. C., Zanardelli, M., Failli, P., & Ghelardini, C. (2012) · Journal of Pain · doi:10.1016/j.jpain.2011.11.009 · Cited by 194
Ta, L. E., Bieber, A. J., Carlton, S. M., Loprinzi, C. L., Low, P. A., & Windebank, A. J. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-15 · Cited by 193
Tanner, K. D., Levine, J. D., & Topp, K. S. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980615)395:4<481::aid-cne5>3.0.co;2-y · Cited by 188
Cata, J. P., Weng, H., Lee, B., Reuben, J. M., & Dougherty, P. M. (2006) · PubMed · Cited by 187
Kim, D.-K., Tolliver, T. J., Huang, S.-J., Martin, B. J., Andrews, A. M., Wichems, C., Holmes, A., Lesch, K.-P., & Murphy, D. L. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.010 · Cited by 185
Dysregulation of Cellular Calcium Homeostasis in Chemotherapy-Evoked Painful Peripheral Neuropathy
Siau, C., & Bennett, G. J. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000204318.35194.ed · Cited by 183
Martin, L. J., Gertz, B., Pan, Y., Price, A. C., Molkentin, J. D., & Chang, Q. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.02.015 · Cited by 180
Taylor-Clark, T. E., Ghatta, S., Bettner, W., & Undem, B. J. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054445 · Cited by 180
Xiao, W., Boroujerdi, A., Bennett, G. J., & Luo, Z. D. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.044 · Cited by 177
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Sprowl, J. A., Ciarimboli, G., Lancaster, C. S., Giovinazzo, H., Gibson, A. A., Du, G., Janke, L. J., Cavaletti, G., Shields, A. F., & Sparreboom, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305321110 · Cited by 175
Xiao, W. H., & Bennett, G. J. (2008) · Pain · doi:10.1016/j.pain.2007.06.001 · Cited by 174
Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat
Ling, B., Authier, N., Balayssac, D., Eschalier, A., & Coudoré, F. (2006) · Pain · doi:10.1016/j.pain.2006.09.016 · Cited by 170
Jin, H. W., Flatters, S. J. L., Xiao, W. H., Mulhern, H. L., & Bennett, G. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.001 · Cited by 167
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2000) · PubMed · Cited by 167
Mironov, S. L., Ivannikov, M. V., & Johansson, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409819200 · Cited by 164
Taxol Neuropathy: Electrodiagnostic and Sural Nerve Biopsy Findings
Sahenk, Z. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540190110024 · Cited by 163
Yonezawa, A., & Inui, K.-I. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.016 · Cited by 163
Mollman, J. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220210 · Cited by 163
Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation
Madiraju, P., Pande, S. V., Prentki, M., & Madiraju, S. R. M. (2009) · Epigenetics · doi:10.4161/epi.4.6.9767 · Cited by 161
Bortezomib: A Review of its Use in Patients with Multiple Myeloma
Curran, M. P., & McKeage, K. (2009) · Drugs · doi:10.2165/00003495-200969070-00006 · Cited by 161
Nieto, F. R., Entrena, J. M., Cendán, C. M., Pozo, E. D., Vela, J. M., & Baeyens, J. M. (2007) · Pain · doi:10.1016/j.pain.2007.10.012 · Cited by 161
Gauchan, P., Andoh, T., Kato, A., & Kuraishi, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.029 · Cited by 160
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2001) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2001.01008-5.x · Cited by 157
Long term effects of vincristine on the peripheral nervous system
Postma, T. J., Benard, B. A., Huijgens, P. C., Ossenkoppele, G. J., & Heimans, J. J. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01050259 · Cited by 154
Boehmerle, W., Splittgerber, U., Lazarus, M. B., McKenzie, K. M., Johnston, D. G., Austin, D. J., & Ehrlich, B. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607240103 · Cited by 153
Dzagnidze, A., Katsarava, Z., Makhalova, J., Liedert, B., Yoon, M., Kaube, H., Limmroth, V., & Thomale, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0523-07.2007 · Cited by 152
Holzer, A. K., Katano, K., Klomp, L. W. J., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0748 · Cited by 143
Inhibition of Paclitaxel-Induced A-Fiber Hypersensitization by Gabapentin
Matsumoto, M., Inoue, M., Hald, A., Xie, W., & Ueda, H. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103614 · Cited by 142
Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody
Yokoseki, A., Saji, E., Arakawa, M., Kosaka, T., Hokari, M., Toyoshima, Y., Okamoto, K., Takeda, S., Sanpei, K., Kikuchi, H., et al. (2013) · Brain · doi:10.1093/brain/awt314 · Cited by 142
Webster, R. G., Brain, K. L., Wilson, R. H., Grem, J. L., & Vincent, A. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706407 · Cited by 136
McDonald, E. S., & Windebank, A. J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0468 · Cited by 135
Jiang, Y., Guo, C., Vasko, M. R., & Kelley, M. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1173 · Cited by 135
DNA Repair capacity and cisplatin sensitivity of human testis tumour cells
Köberle, B., Grimaldi, K. A., Sunters, A., Hartley, J. A., Kèlland, L. R., & Masters, J. R. (1997) · International Journal of Cancer · Cited by 132
Spinal Astrocyte Gap Junctions Contribute to Oxaliplatin-Induced Mechanical Hypersensitivity
Yoon, S. Y., Robinson, C. R., Zhang, H., & Dougherty, P. M. (2013) · Journal of Pain · doi:10.1016/j.jpain.2012.11.002 · Cited by 128
Kim, H. K., Zhang, Y. P., Gwak, Y. S., & Abdi, S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ca31bd · Cited by 127
Yang, I. H., Siddique, R., Hosmane, S., Thakor, N. V., & Höke, A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.017 · Cited by 124
Nociceptor Hyper-Responsiveness during Vincristine-Induced Painful Peripheral Neuropathy in the Rat
Tanner, K. D., Reichling, D. B., & Levine, J. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06480.1998 · Cited by 123
Muthuraman, A., Jaggi, A. S., Singh, N., & Singh, D. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.042 · Cited by 120
Poruchynsky, M. S., Sackett, D. L., Robey, R. W., Ward, Y., Annunziata, C. M., & Fojo, T. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5625 · Cited by 117
Eide, P. K., & Hole, K. (1993) · Cephalalgia · doi:10.1046/j.1468-2982.1993.1302075.x · Cited by 117
Cavaletti, G., Marzorati, L., Bogliun, G., Colombo, N., Marzola, M. M., Pittelli, M., & Tredici, G. (1992) · Cancer · Cited by 116
Calpain inhibition protects against Taxol-induced sensory neuropathy
Wang, M. S. (2003) · Brain · doi:10.1093/brain/awh078 · Cited by 116
Sensitization of Capsaicin and Icilin Responses in Oxaliplatin Treated Adult Rat DRG Neurons
Anand, U., Otto, W. R., & Anand, P. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-82 · Cited by 116
Argyriou, A. A., Cavaletti, G., Antonacopoulou, A. G., Genazzani, A. A., Briani, C., Bruna, J., Terrazzino, S., Velasco, R., Alberti, P., Campagnolo, M., et al. (2013) · Cancer · doi:10.1002/cncr.28234 · Cited by 115
Ji, X., Qian, N., Zhang, T., Li, J., Li, X., Wang, P., Zhao, D., Huang, G., Zhang, L., Zhou, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060733 · Cited by 114
Du, Z., Zhang, H.-Y., Meng, X., Guan, Y., & Wang, H.-Q. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-56 · Cited by 111
Theiß, C., & Meller, K. (2000) · Cell and Tissue Research · doi:10.1007/s004410050019 · Cited by 110
Cisplatin neuropathy: clinical course and neurophysiological findings
LoMonaco, M., Milone, M., Batocchi, A. P., Padua, L., Restuccia, D., & Tonali, P. A. (1992) · Journal of Neurology · doi:10.1007/bf00839140 · Cited by 109
Theiß, C., & Meller, K. (1999) · Cell and Tissue Research · doi:10.1007/s004419900120 · Cited by 108
Subclinical Inflammation and Diabetic Polyneuropathy
Herder, C., Lankisch, M., Ziegler, D., Rathmann, W., Köenig, W., Illig, T., Döring, A., Thorand, B., Holle, R., Giani, G., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2011 · Cited by 108
Membrane Transporters as Mediators of Cisplatin Effects and Side Effects
Ciarimboli, G. (2012) · Scientifica · doi:10.6064/2012/473829 · Cited by 105
Lim, S., Choi, J. E., Kang, H. S., & Han, S. I. (2009) · International Journal of Cancer · doi:10.1002/ijc.24853 · Cited by 103
Moalem‐Taylor, G., Grafe, P., & Tracey, D. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.046 · Cited by 99
Structure of the Ctr1 copper trans‘PORE’ter reveals novel architecture
Nose, Y., Rees, E. M., & Thiele, D. J. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.09.003 · Cited by 98
Mannelli, L. D. C., Pacini, A., Matera, C., Zanardelli, M., Mello, T., Amici, M. D., Dallanoce, C., & Ghelardini, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.034 · Cited by 96
Kirchmair, R., Tietz, A. B., Panagiotou, E. M., Walter, D. H., Silver, M., Yoon, Y., Schratzberger, P., Weber, A. C., KUSANO, K. F., Weinberg, D. H., et al. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300019 · Cited by 92
de la Vega, L., Muñóz, E., Calzado, M. A., Lieb, K., Candelario‐Jalil, E., Gschaidmeir, H., Färber, L., Mueller, W., Stratz, T., & Fiebich, B. L. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.031 · Cited by 91
Park, S. A., Choi, K. S., Bang, J. H., Huh, K., & Kim, S. U. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750946.x · Cited by 90
Langerhans cells express inducible nitric oxide synthase and produce nitric oxide.
Qureshi, A. A., Hosoi, J., Xu, S., Takashima, A., Granstein, R., & Lerner, E. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12330572 · Cited by 90
Kannurpatti, S. S., Joshi, P. G., & Joshi, N. B. (2000) · Neurochemical Research · doi:10.1023/a:1026602100160 · Cited by 85
The Role of Reactive Oxygen Species (ROS) in Persistent Pain
Chung, J. M. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.3 · Cited by 83
Progressive paresthesias after cessation of therapy with very high-dose cisplatin
Grunberg, S. M., Sonka, S., Stevenson, L. L., et al. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00694340 · Cited by 82
Krarup‐Hansen, Rietz, Krarup, Heydorn, Rørth, & Schmalbruch (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00160.x · Cited by 82
Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem
Swerdlow, R. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1676 · Cited by 81
Permeation of proteins from the blood into peripheral nerves and ganglia
Allen, D. T., & Kiernan, J. A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90192-9 · Cited by 75
Meregalli, C., Chiorazzi, A., Carozzi, V., Canta, A., Sala, B., Colombo, M., Oggioni, N., Ceresa, C., Foudah, D., Russa, F. L., et al. (2013) · Cell Cycle · doi:10.4161/cc.27476 · Cited by 75
Self-citationKirchmair, R., Walter, D. H., Ii, M., Rittig, K., Tietz, A. B., Murayama, T., Emanueli, C., Silver, M., Wecker, A., Amant, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.470849 · Cited by 75
Liu, J. J., Jamieson, S. M. F., Subramaniam, J., Ip, V., Jong, N. N., Mercer, J. F. B., & McKeage, M. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1017-6 · Cited by 71
Sensory Neurons, Ion Channels, Inflammation and the Onset of Neuropathic Pain
Stemkowski, P. L., & Smith, P. A. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013937 · Cited by 71
Carozzi, V., Chiorazzi, A., Canta, A., Lapidus, R. G., Slusher, B. S., Wozniak, K. M., & Cavaletti, G. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9114-1 · Cited by 68
Self-citationMembrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs
Liu, J. J., Lu, J., & McKeage, M. J. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803251199 · Cited by 68
Nydahl, K. S., Skinner, K., Julius, D. J., & Basbaum, A. I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03284.x · Cited by 67
Thalidomide Inhibits Tumor Necrosis Factor-α Production and Antigen Presentation by Langerhans Cells
Deng, L., Ding, W., & Granstein, R. D. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12565.x · Cited by 66
Virmani, A., Gaetani, F., & BINIENDA, Z. K. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00024.x · Cited by 66
Shimizu, I., Iida, T., Horiuchi, N., & Caterina, M. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084277 · Cited by 65
Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features
Isoardo, G., Bergui, M., Durelli, L., et al. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00203.x · Cited by 64
Quartu, M., Carozzi, V., Dorsey, S. G., Serra, M. P., Poddighe, L., Picci, C., Boi, M., Melis, T., Fiacco, M. D., Meregalli, C., et al. (2014) · BioMed Research International · doi:10.1155/2014/180428 · Cited by 62
Self-citationThibault, K., Calvino, B., Rivals, I., Marchand, F., Dubacq, S., McMahon, S. B., & Pezet, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091297 · Cited by 60
NGF protects Dorsal Root Ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2
Scuteri, A., Galimberti, A., Ravasi, M., Pasini, S., Donzelli, E., Cavaletti, G., & Tredici, G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.028 · Cited by 60
Nishida, K., Kuchiiwa, S., Oiso, S., Futagawa, T., Masuda, S., Takeda, Y., & Yamada, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00877.x · Cited by 57
DNA damage response in peripheral nervous system: Coping with cancer therapy-induced DNA lesions
Englander, E. W. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.020 · Cited by 57
Safaei, R., Adams, P. L., Maktabi, M. H., Mathews, R. A., & Howell, S. B. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.02.016 · Cited by 56
Favilli, F., Marraccini, P., Iantomasi, T., & VINCENZINI, M. T. (1997) · British Journal Of Nutrition · doi:10.1079/bjn19970147 · Cited by 54
Giannoccaro, M. P., Donadio, V. A., Gomis‐Pérez, C., Borsini, W., Stasi, V. D., & Liguori, R. (2011) · Neurological Sciences · doi:10.1007/s10072-010-0475-2 · Cited by 52
Pascual, D., Goicoechea, C., Burgos, E., & Martín, M. I. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.009 · Cited by 52
Caselli, G., Meregalli, C., Ceresa, Canta, A., Carozzi, V., Chiorazzi, A., Sala, Oggioni, Lanza, M., Letari, O., et al. (2012) · Journal of Pain Research · doi:10.2147/jpr.s32122 · Cited by 50
Self-citationZadina, J. E. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.89.203 · Cited by 50
Shahshahan, M., Beckley, M. N., & Jazirehi, A. R. (2011) · Europe PMC (PubMed Central) · Cited by 49
Shishkin, V., Potapenko, E. S., Kostyuk, E. P., Girnyk, O. V., Voitenko, N. V., & Kostyuk, P. G. (2002) · Cell Calcium · doi:10.1016/s0143-4160(02)00095-7 · Cited by 44
Seki, N., Toh, U., Sayers, T. J., Fujii, T., Miyagi, M., Akagi, Y., Kusukawa, J., Kage, M., Shirouzu, K., & Yamana, H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0918 · Cited by 41
Effect of oxidative stress on UDP-glucuronosyltransferases in rat astrocytes
Grădinaru, D., Minn, A.-L., Artur, Y., Minn, A., & Heydel, J. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.014 · Cited by 40
Wang, C., Cherng, W., Yang, N., Hsu, C.-M., Yeh, C., Lan, Y.-J., Wang, J., & Verma, S. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00543.2007 · Cited by 40
Sittl, R., Carr, R. W., Fleckenstein, J., & Grafe, P. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.07.006 · Cited by 40
Hansen, N., Üçeyler, N., Palm, F., Zelenka, M., Biko, L., Lesch, K., Gerlach, M., & Sommer, C. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.035 · Cited by 39
Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blachly‐Dyson, E., Lisa, F. D., & Forte, M. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05297.x · Cited by 39
Urazaev, A. K., Grossfeld, R. M., Fletcher, P. L., Speno, H., Gafurov, B. S., Buttram, J. G., & Lieberman, E. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00270-6 · Cited by 33
Ibi, D., Nitta, A., Ishige, K., Cen, X., Ohtakara, T., Nabeshima, T., & Ito, Y. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.09.004 · Cited by 32
Palm, F., Mößner, R., Chen, Y., He, L., Gerlach, M., Bischofs, S., Riederer, P. F., Lesch, K., & Sommer, C. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2007.11.009 · Cited by 30
Regulation of tumor necrosis factor cytotoxicity by calcineurin
Kantrow, S. P., Gierman, J. L., Jaligam, V. R., Zhang, P., Piantadosi, C. A., Summer, W. R., & Lancaster, J. R. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02083-4 · Cited by 27
Papa, L., & Rockwell, P. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0182-0 · Cited by 26
Thibault, K., Rivals, I., M’Dahoma, S., Dubacq, S., Pezet, S., & Calvino, B. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0095-4 · Cited by 25
Linking the activity of bortezomib in multiple myeloma and autoimmune diseases
Škrott, Z., & Cvek, B. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.05.003 · Cited by 25
Nakano, A., Abe, M., Oda, A., Amou, H., Hiasa, M., Nakamura, S., Miki, H., Harada, T., Fujii, S., Kagawa, K., et al. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0850-7 · Cited by 25
Bortezomib in Multiple Myeloma: A Practice Guideline
Kouroukis, C. T., Baldassarre, F. G., Haynes, A. E., Imrie, K., Reece, D. E., & Cheung, M. C. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.11.022 · Cited by 24
Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model.
Chiorazzi, A., Canta, A., Meregalli, C., Carozzi, V., Sala, B., Oggioni, N., Monbaliu, J. G., de Velde, H. J. V., & Cavaletti, G. (2013) · PubMed · Cited by 23
Self-citationYang, Y., Zhang, Y., Lin, G.-A., Xie, H.-Q., Pan, H., Huang, B.-Q., Liu, J., Liu, H., Zhang, N., Li, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089583 · Cited by 23
Nakayama, J., Yamamoto, N., Hamano, K., Iwasaki, N., Ohta, M., Nakahara, S., Horigome, Y., Nakahara, C., Noguchi, E., Shiono, J., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00651-1 · Cited by 22
Cited by
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 829
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Starobova, H., & Vetter, I. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00174 · Cited by 648
Advances in Toxicological Research of the Anticancer Drug Cisplatin
Qi, L., Luo, Q., Zhang, Y., Jia, F., Zhao, Y., & Wang, F. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00204 · Cited by 440
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Lange, C., Storkebaum, E., de Almodóvar, C. R., Dewerchin, M., & Carmeliet, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.88 · Cited by 382
Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
Geisler, S., Doan, R. A., Strickland, A., Huang, X., Milbrandt, J., & DiAntonio, A. (2016) · Brain · doi:10.1093/brain/aww251 · Cited by 270
Metadata
- Authors
- Carozzi, V. A., Canta, A., & Chiorazzi, A.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 596
- Pages
- 90-107
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2071620144
- Cited by
- 431
- References
- 188
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.